| QS11 |
ENSG00000088970.11 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000104691.10 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000125514.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000132832.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000152487.6 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000157306.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000164621.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000170846.11 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000172965.10 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000175773.8 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000175873.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000175873.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000178193.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000178412.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000178412.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000178803.6 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000179219.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000179935.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000180769.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000180846.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000181097.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000182057.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000182109.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000182376.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000182648.7 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000184274.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000184324.11 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000184324.11 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000185433.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000186019.10 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000188206.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000188206.5 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000188206.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000189149.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000196668.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000196960.3 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000197463.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000197463.8 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000197813.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000198221.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000203307.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000203335.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000203362.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000203496.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000203497.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000203650.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000203801.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000203801.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000203808.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000204011.4 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000204272.6 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000204625.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000204758.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000204791.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000204860.4 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000204934.6 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000204934.6 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000205041.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000205500.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000205662.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000206176.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000206417.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000212163.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000212163.2 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000212552.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000213742.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000213742.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000213793.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000213971.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000214049.6 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000214401.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000214401.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000214407.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000214546.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000214733.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000214803.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000214955.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000215256.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000215374.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000215424.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000215863.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000215863.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000215866.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000215869.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000218839.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000219665.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000223356.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000223379.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000223396.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000223401.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000223442.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000223473.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000223477.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000223552.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000223571.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000223573.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000223598.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000223633.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000223685.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000223695.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000223711.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000223749.3 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000223759.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000223759.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000223779.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000223797.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000223799.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000223804.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000223813.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000223821.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000223839.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000223842.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000223842.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000223882.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000224023.6 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000224043.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000224043.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000224049.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000224079.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000224107.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000224116.2 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000224142.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000224167.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000224173.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000224238.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000224376.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000224394.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000224394.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000224481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000224509.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000224616.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000224635.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000224698.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000224707.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000224707.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000224733.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000224764.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000224764.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000224790.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000224844.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000224863.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000224875.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000224884.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000224884.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000224885.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000224932.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000224933.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000224973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000224992.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000225037.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000225087.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000225113.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000225113.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000225163.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000225177.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000225180.2 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000225205.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000225216.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000225255.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000225302.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000225335.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000225383.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000225393.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000225434.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000225442.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000225535.2 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000225541.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000225541.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000225555.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000225643.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000225675.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000225721.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000225761.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000225791.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000225826.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000225836.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000225839.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000225873.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000225891.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000225938.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000225952.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000225953.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000225956.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000225956.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000226007.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000226009.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000226029.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000226067.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000226091.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000226155.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000226167.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000226179.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000226251.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000226281.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000226287.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000226287.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000226328.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000226328.2 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000226334.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000226377.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000226380.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000226386.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000226403.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000226419.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000226440.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000226471.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000226516.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000226548.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000226562.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000226609.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000226637.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000226637.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000226637.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000226688.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000226747.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000226754.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000226780.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000226890.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000226950.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000226965.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000227014.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000227060.2 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000227110.2 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000227214.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000227218.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000227245.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000227245.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000227248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000227279.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000227285.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000227285.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000227355.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000227372.6 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000227392.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000227409.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000227431.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000227431.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000227431.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000227456.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000227484.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000227486.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000227502.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000227518.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000227542.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000227544.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000227574.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000227640.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000227678.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000227848.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000227963.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000228043.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000228060.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000228065.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000228084.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000228124.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000228140.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000228176.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000228192.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000228203.2 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000228204.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000228223.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000228242.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000228262.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000228274.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000228288.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000228313.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000228315.7 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000228317.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000228340.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000228352.2 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000228358.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000228363.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000228363.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000228369.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000228389.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000228395.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000228395.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000228412.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000228444.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000228470.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000228506.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000228509.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000228521.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000228544.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000228554.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000228614.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000228643.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000228748.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000228748.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000228839.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000228839.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000228857.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000228857.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000228857.2 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000228878.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000228889.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000228917.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000228956.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000229021.2 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000229036.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000229043.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000229065.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000229154.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000229154.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000229160.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000229178.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000229203.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000229267.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000229311.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000229327.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000229327.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000229348.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000229382.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000229404.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000229404.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000229444.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000229487.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000229525.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000229618.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000229645.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000229645.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000229647.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000229697.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000229702.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000229801.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000229801.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000229821.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000229832.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000229839.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000229848.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000229852.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000229867.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000229873.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000229893.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000229893.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000229931.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000229952.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000229953.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000229956.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000229989.3 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000229990.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000229999.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000230013.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000230013.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000230061.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000230084.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000230091.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000230109.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000230140.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000230197.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000230212.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000230319.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000230337.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000230366.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000230408.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000230415.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000230433.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000230433.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000230499.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000230523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000230537.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000230550.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000230550.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000230555.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000230561.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000230561.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000230590.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000230613.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000230806.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000230836.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000230894.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000230896.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000230899.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000230914.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000230914.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000231024.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000231028.4 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000231050.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000231064.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000231098.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000231102.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000231104.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000231119.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000231128.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000231131.2 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000231133.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000231154.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000231156.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000231172.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000231173.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000231193.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000231212.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000231212.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000231252.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000231365.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000231459.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000231473.2 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000231507.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000231528.2 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000231551.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000231551.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000231551.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000231595.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000231636.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000231646.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000231690.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000231709.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000231711.2 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000231721.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000231734.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000231734.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000231734.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000231742.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000231764.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000231806.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000231816.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000231840.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000231840.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000231903.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000231903.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000231948.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000231966.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000232019.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000232028.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000232063.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000232093.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000232098.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000232116.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000232116.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000232118.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000232118.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000232151.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000232160.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000232194.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000232233.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000232311.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000232342.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000232377.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000232377.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000232445.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000232455.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000232470.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000232485.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000232519.2 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000232527.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000232613.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000232642.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000232648.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000232692.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000232698.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000232712.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000232759.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000232759.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000232876.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000232936.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000232949.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000232969.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000233016.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000233033.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000233044.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000233058.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000233110.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000233144.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000233154.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000233178.3 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000233223.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000233237.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000233244.2 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000233244.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000233250.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000233334.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000233367.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000233368.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000233396.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000233411.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000233429.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000233430.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000233430.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000233430.2 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000233496.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000233554.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000233559.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000233593.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000233621.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000233630.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000233661.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000233672.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000233693.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000233694.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000233783.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000233800.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000233871.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000233895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000233912.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000233926.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000233937.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000234006.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000234015.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000234019.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000234019.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000234062.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000234084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000234084.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000234171.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000234199.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000234235.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000234252.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000234264.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000234281.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000234352.5 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000234378.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000234393.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000234428.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000234456.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000234492.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000234494.3 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000234571.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000234572.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000234584.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000234661.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000234705.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000234741.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000234810.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000234818.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000234883.2 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000234902.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000234902.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000234945.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000234978.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000234998.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000235016.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000235033.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000235033.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000235079.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000235092.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000235159.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000235214.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000235214.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000235237.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000235244.3 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000235257.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000235257.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000235262.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000235293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000235358.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000235358.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000235398.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000235398.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000235445.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000235475.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000235488.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000235488.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000235495.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000235529.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000235597.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000235609.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000235641.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000235706.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000235724.4 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000235726.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000235726.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000235770.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000235802.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000235831.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000235837.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000235872.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000235872.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000235910.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000235927.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000235934.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000235954.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000235989.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000235999.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000236031.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000236066.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000236066.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000236094.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000236095.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000236140.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000236266.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000236308.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000236345.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000236423.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000236438.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000236449.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000236457.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000236514.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000236537.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000236558.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000236591.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000236618.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000236643.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000236651.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000236760.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000236772.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000236778.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000236780.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000236833.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000236833.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000236861.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000236871.2 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000236896.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000236908.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000236933.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000236935.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000236943.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000236953.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000236986.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000236986.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000236991.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000237013.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000237017.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000237021.2 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000237036.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000237073.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000237119.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000237126.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000237126.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000237126.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000237187.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000237234.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000237280.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000237328.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000237338.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000237343.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000237424.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000237476.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000237481.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000237491.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000237505.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000237517.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000237523.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000237548.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000237605.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000237721.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000237773.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000237803.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000237805.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000237853.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000237877.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000237883.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000237886.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000237892.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000237899.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000237903.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000237903.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000237934.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000237943.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000237950.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000237978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000237980.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000238045.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000238078.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000238107.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000238122.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000238142.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000238198.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000238279.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000238280.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000239002.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000239219.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000239377.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000239377.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000239415.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000239453.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000239523.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000239608.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000239705.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000240045.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000240211.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000240219.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000240254.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000240254.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000240288.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000240291.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000240373.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000240497.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000240790.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000240990.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000240996.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000241014.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000241163.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000241280.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000241316.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000241409.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000241449.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000241520.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000241560.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000241570.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000241596.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000241933.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000241954.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000241956.5 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000242082.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000242242.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000242242.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000242290.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000242370.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000242474.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000242474.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000242474.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000242474.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000242791.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000243533.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000244036.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000244260.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000244300.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000244332.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000244349.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000244459.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000244649.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000244676.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000245146.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000245149.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000245311.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000245534.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000245552.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000245552.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000245556.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000245571.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000245598.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000245954.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000246089.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000246090.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000246145.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000246174.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000246228.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000246273.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000246308.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000246560.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000246640.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000246731.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000246777.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000246790.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000246792.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000246859.2 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000247095.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000247363.2 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000247373.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000247516.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000247556.2 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000247624.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000247679.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000247828.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000247853.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000247925.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000247934.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000247934.3 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000247982.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000248092.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000248175.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000248187.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000248221.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000248254.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000248265.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000248275.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000248318.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000248323.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000248360.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000248367.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000248399.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000248514.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000248559.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000248607.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000248668.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000248677.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000248698.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000248724.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000248787.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000248839.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000248866.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000248890.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000248932.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000248968.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000248996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000249035.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000249042.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000249085.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000249207.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000249207.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000249234.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000249252.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000249293.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000249310.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000249328.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000249341.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000249379.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000249412.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000249412.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000249478.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000249497.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000249550.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000249593.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000249595.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000249595.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000249599.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000249609.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000249673.2 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000249699.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000249706.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000249740.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000249825.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000249859.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000249899.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000249993.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000250033.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000250056.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000250061.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000250156.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000250167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000250260.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000250260.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000250266.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000250267.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000250267.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000250282.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000250286.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000250432.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000250447.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000250451.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000250511.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000250546.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000250602.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000250629.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000250659.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000250734.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000250748.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000250874.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000250899.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000250900.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000250948.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000250988.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000251003.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000251022.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000251136.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000251168.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000251175.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000251221.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000251323.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000251359.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000251364.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000251414.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000251460.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000251580.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000251603.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000251603.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000251661.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000251661.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000251675.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000253116.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000253121.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000253172.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000253187.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000253197.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000253210.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000253263.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000253302.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000253392.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000253395.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000253508.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000253562.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000253641.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000253641.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000253671.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000253706.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000253708.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000253708.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000253733.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000253741.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000253744.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000253744.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000253744.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000253848.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000253859.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000253875.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000253875.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000253931.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000253982.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000254002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000254003.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000254008.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000254034.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000254109.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000254205.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000254207.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000254207.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000254231.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000254233.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000254258.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000254266.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000254290.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000254295.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000254315.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000254333.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000254363.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000254409.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000254409.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000254418.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000254428.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000254444.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000254461.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000254528.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000254538.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000254554.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000254556.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000254577.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000254604.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000254676.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000254718.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000254739.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000254777.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000254791.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000254812.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000254821.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000254855.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000254879.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000254900.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000254907.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000254907.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000254910.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000254910.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000254936.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000254951.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000254964.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000254966.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000254967.2 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000254981.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000255008.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000255045.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000255050.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000255050.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000255121.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000255121.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000255135.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000255139.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000255164.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000255164.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000255165.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000255186.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000255247.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000255299.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000255310.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000255310.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000255322.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000255343.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000255355.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000255366.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000255375.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000255434.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000255449.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000255456.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000255474.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000255476.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000255509.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000255520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000255557.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000255559.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000255644.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000255650.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000255672.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000255717.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000255847.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000255886.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000256116.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000256128.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000256150.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000256196.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000256196.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000256196.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000256232.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000256234.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000256268.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000256442.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000256448.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000256448.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000256571.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000256603.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000256670.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000256712.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000256746.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000256747.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000256894.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000256897.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000256940.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000256967.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000257027.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000257058.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000257083.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000257097.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000257261.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000257264.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000257310.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000257433.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000257475.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000257507.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000257526.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000257563.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000257563.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000257612.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000257636.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000257636.2 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000257642.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000257671.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000257740.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000257808.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000257824.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000257880.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000257913.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000257925.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000257947.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000257947.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000258017.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000258086.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000258101.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000258102.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000258249.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000258274.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000258323.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000258325.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000258334.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000258342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000258346.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000258355.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000258457.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000258458.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000258479.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000258515.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000258521.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000258537.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000258576.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000258736.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000258760.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000258791.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000258857.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000258902.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000258903.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000258904.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000258920.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000258929.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000258929.2 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000258935.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000258940.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000258946.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000258959.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000259001.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000259062.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000259065.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000259118.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000259125.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000259146.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000259146.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000259182.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000259201.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000259219.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000259244.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000259274.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000259277.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000259287.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000259294.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000259327.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000259327.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000259345.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000259364.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000259364.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000259365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000259376.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000259407.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000259410.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000259418.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000259423.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000259426.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000259432.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000259442.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000259450.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000259457.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000259488.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000259499.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000259521.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000259521.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000259523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000259527.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000259548.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000259548.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000259583.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000259598.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000259617.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000259640.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000259644.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000259645.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000259652.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000259654.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000259659.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000259668.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000259672.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000259687.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000259700.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000259709.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000259714.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000259715.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000259727.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000259764.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000259767.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000259782.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000259783.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000259792.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000259793.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000259796.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000259802.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000259863.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000259891.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000259920.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000259926.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000259942.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000259959.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000259959.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000260000.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000260000.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000260008.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000260017.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000260032.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000260035.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000260037.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000260059.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000260060.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000260070.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000260086.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000260118.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000260141.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000260145.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000260160.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000260167.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000260176.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000260179.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000260190.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000260193.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000260213.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000260231.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000260233.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000260248.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000260310.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000260316.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000260317.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000260317.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000260331.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000260331.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000260337.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000260351.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000260366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000260366.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000260367.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000260396.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000260417.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000260423.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000260423.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000260436.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000260436.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000260436.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000260475.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000260495.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000260532.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000260534.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000260536.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000260579.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000260579.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000260583.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000260585.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000260592.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000260616.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000260618.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000260626.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000260626.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000260635.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000260635.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000260643.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000260647.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000260651.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000260698.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000260698.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000260708.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000260742.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000260743.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000260787.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000260796.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000260796.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000260803.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000260804.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000260814.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000260816.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000260831.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000260874.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000260896.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000260905.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000260911.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000260911.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000260917.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000260920.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000260924.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000260924.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000260949.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000260949.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000260953.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000260955.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000260955.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000260971.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000261000.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000261008.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000261019.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000261040.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000261045.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000261068.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000261079.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000261087.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000261101.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000261118.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000261126.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000261131.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000261135.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000261167.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000261168.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000261170.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000261173.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000261200.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000261216.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000261248.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000261254.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000261267.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000261270.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000261273.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000261280.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000261291.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000261302.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000261305.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000261326.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000261353.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000261366.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000261372.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000261373.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000261374.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000261374.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000261384.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000261420.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000261428.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000261438.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000261442.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000261447.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000261476.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000261490.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000261512.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000261523.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000261523.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000261523.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000261523.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000261533.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000261542.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000261542.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000261542.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000261560.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000261584.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000261584.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000261584.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000261613.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000261633.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000261634.2 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000261644.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000261669.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000261673.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000261697.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000261744.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000261766.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000261773.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000261775.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000261783.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000261829.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000261840.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000261872.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000261889.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000261889.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000261996.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000262136.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000262155.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000262171.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000262172.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000262185.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000262194.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000262194.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000262412.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000262454.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000262468.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000262619.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000262668.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000262686.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000262721.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000262768.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000262768.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000262848.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000262881.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000262944.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000263011.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000263033.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000263050.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000263072.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000263096.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000263098.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000263214.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000263280.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000263327.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000263327.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000263338.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000263370.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000263388.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000263477.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000263727.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000263731.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000263786.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000263859.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000263916.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000263934.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000263938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000264026.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000264031.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000264188.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000264188.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000264222.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000264222.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000264235.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000264270.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000264272.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000264469.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000264486.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000264513.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000264513.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000264527.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000264546.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000264577.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000264589.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000264608.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000264647.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000264673.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000264769.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000264808.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000264829.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000264853.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000264924.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000264937.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000265094.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000265142.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000265206.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000265334.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000265342.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000265394.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000265490.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000265496.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000265542.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000265656.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000265702.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000265728.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000265787.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000265800.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000265888.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000265908.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000265943.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000265962.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000266088.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000266236.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000266256.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000266289.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000266289.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000266401.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000266402.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000266445.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000266538.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000266651.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000266654.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000266709.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000266717.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000266801.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000266895.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000266912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000266912.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000266918.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000266926.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000266933.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000266969.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000266970.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000266975.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000266983.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000266987.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000267002.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000267004.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000267009.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000267009.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000267010.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000267011.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000267040.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000267040.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000267042.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000267044.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000267047.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000267063.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000267069.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000267073.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000267082.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000267093.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000267095.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000267096.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000267104.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000267108.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000267108.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000267138.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000267141.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000267143.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000267143.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000267149.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000267150.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000267152.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000267152.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000267159.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000267161.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000267166.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000267169.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000267174.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000267191.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000267194.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000267199.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000267219.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000267248.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000267254.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000267255.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000267265.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000267273.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000267282.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000267298.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000267317.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000267321.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000267380.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000267381.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000267383.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000267397.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000267414.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000267439.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000267449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000267470.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000267474.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000267475.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000267480.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000267480.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000267480.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000267481.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000267501.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000267547.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000267565.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000267583.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000267586.2 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000267612.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000267638.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000267649.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000267649.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000267654.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000267655.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000267655.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000267658.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000267677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000267743.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000267745.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000267751.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000267758.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000267787.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000267798.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000267874.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000267898.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000267904.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000267922.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000267924.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000267934.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000268015.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000268015.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000268199.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000268266.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000268289.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000268307.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000268340.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000268362.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000268364.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000268375.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000268458.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000268518.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000268544.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000268564.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000268568.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000268583.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000268584.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000268605.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000268621.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000268621.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000268812.2 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000268836.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000268836.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000268889.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000268889.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000269038.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000269044.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000269054.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000269177.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000269194.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000269235.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000269365.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000269444.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000269473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000269481.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000269609.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000269614.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000269640.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000269646.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000269680.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000269680.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000269688.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000269694.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000269825.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000269825.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000269836.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000269873.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000269894.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000269899.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000269903.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000269906.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000269918.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000269923.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000269951.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000269959.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000269961.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000269973.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000269974.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000270006.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000270031.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000270035.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000270036.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000270062.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000270068.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000270077.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000270083.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000270100.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000270102.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000270102.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000270109.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000270165.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000270170.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000270332.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000270361.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000270426.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000270557.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000270562.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000270562.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000270589.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000270681.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000270720.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000270760.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000270988.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000271086.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000271133.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000271156.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000271192.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000271265.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000271270.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000271308.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000271359.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000271384.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000271551.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000271553.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000271554.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000271579.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000271734.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000271737.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000271751.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000271752.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000271757.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000271762.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000271782.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000271782.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000271788.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000271821.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000271824.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000271826.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000271835.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000271840.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000271862.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000271862.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000271869.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000271869.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000271874.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000271888.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000271912.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000271912.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000271913.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000271927.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000271927.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000271948.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000271948.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000271964.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000271964.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000271966.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000271975.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000271975.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000271981.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000271997.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000272002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000272004.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000272005.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000272024.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000272029.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000272043.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000272048.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000272065.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000272068.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000272070.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000272070.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000272076.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000272077.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000272077.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000272081.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000272108.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000272109.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000272128.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000272128.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000272138.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000272142.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000272146.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000272181.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000272183.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000272192.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000272198.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000272205.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000272209.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000272216.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000272217.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000272219.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000272221.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000272226.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000272240.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000272263.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000272263.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000272273.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000272273.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000272288.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000272301.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000272312.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000272327.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000272334.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000272338.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000272341.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000272343.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000272349.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000272366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000272373.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000272377.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000272379.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000272382.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000272402.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000272417.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000272426.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000272452.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000272452.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000272452.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000272452.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000272463.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000272463.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000272482.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000272498.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000272498.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000272508.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000272516.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000272524.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000272529.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000272529.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000272541.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000272554.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000272567.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000272574.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000272588.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000272604.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000272659.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000272660.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000272663.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000272667.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000272668.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000272669.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000272677.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000272689.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000272699.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000272699.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000272734.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000272755.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000272755.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000272761.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000272763.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000272791.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000272792.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000272799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000272799.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000272824.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000272829.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000272829.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000272848.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000272862.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000272864.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000272885.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000272905.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000272917.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000272966.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000272966.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000272970.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000272989.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000272992.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000273000.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000273011.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000273038.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000273056.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000273073.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000273073.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000273073.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000273076.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000273091.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000273118.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000273133.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000273148.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000273174.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000273176.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| QS11 |
ENSG00000273185.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000273190.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000273190.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000273209.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000273218.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000273243.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| QS11 |
ENSG00000273247.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000273257.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| QS11 |
ENSG00000273281.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000273287.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000273290.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000273295.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000273302.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000273308.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000273309.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000273319.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000273319.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000273335.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| QS11 |
ENSG00000273344.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000273344.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000273353.1 |
Predicted lncRNA |
Esophageal cancer |
|
| QS11 |
ENSG00000273353.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000273355.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| QS11 |
ENSG00000273373.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000273375.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| QS11 |
ENSG00000273399.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| QS11 |
ENSG00000273403.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000273451.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| QS11 |
ENSG00000273451.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| QS11 |
ENSG00000273454.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| QS11 |
ENSG00000273454.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| QS11 |
ENSG00000273473.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| QS11 |
ENSG00000273483.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000273487.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| QS11 |
ENSG00000273488.1 |
Predicted lncRNA |
Sarcoma |
|
| QS11 |
ENSG00000273493.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
